Evaluation of mRNA by Q-RTPCR and protein expression by AQUA of the M2 subunit of ribonucleotide reductase (RRM2) in human tumors

被引：18
|
作者：
Kolesar, Jill [1 ,2 ]
Huang, Wei [1 ,3 ]
Eickhoff, Jens [1 ,4 ]
Hahn, Kristine [1 ,5 ]
Alberti, Dona [1 ,5 ]
Attia, Steven [1 ,5 ]
Schelman, William [1 ,5 ]
Holen, Kyle [1 ,5 ]
Traynor, Anne [1 ,5 ]
Ivy, Percy [6 ]
Wilding, George [1 ,5 ]
机构：
[1] Univ Wisconsin, Paul P Carbone Comprehens Canc Ctr, Madison, WI 53792 USA
[2] Univ Wisconsin, Sch Pharm, Madison, WI 53792 USA
[3] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pathol, Madison, WI 53792 USA
[4] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biostat, Madison, WI 53792 USA
[5] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, Madison, WI 53792 USA
[6] NCI, Canc Therapy Evaluat Program, Bethesda, MD 20892 USA
来源：
CANCER CHEMOTHERAPY AND PHARMACOLOGY | 2009年 / 64卷 / 01期
关键词：
Triapine (R); 3-Aminopyridine-2-carboxaldehyde thiosemicarbazone; Ribonucleotide reductase; Automated quantitative immunohistochemistry (AQUA); Quantitative real time PCR; PHASE-II; CELL-PROLIFERATION; R2; COMPONENT; IN-VITRO; CANCER; OVEREXPRESSION; GEMCITABINE; TRANSFORMATION; RESISTANCE; INCREASES;
D O I：
10.1007/s00280-008-0845-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The purpose of this study was to evaluate baseline RRM2 protein and gene expression in tumors of patients receiving 3-AP. Tumor blocks from patients enrolled in phase I and II clinical studies using 3-AP, were evaluated for RRM2 gene and protein expression by quantitative real time polymerase chain reaction (Q-RTPCR) and automated quantitative analysis (AQUA). Esophageal and gastric cancers overexpressed RRM2 protein when compared to prostate cancer (Z-score, 0.68 +/- A 0.94 SD, vs 0.41 +/- A 0.84 SD, respectively; p = 0.04). Esophageal and gastric cancers also overexpressed RRM2 mRNA when compared to prostate cancer (relative gene expression 2.56 +/- A 1.49 SD, vs 0.29 +/- A 0.20 SD, respectively; p = 0.02). Protein and gene expression were moderately associated (Spearman's rank correlation = 0.30; p = 0.12). RRM2 gene and protein expression varies by tumor type.
引用
收藏
页码：79 / 86
页数：8
相关论文
共 50 条
  • [21] SNPS IN RIBONUCLEOTIDE REDUCTASE GENES RRM1 AND RRM2 ARE ASSOCIATED WITH MRNA EXPRESSION AND RESPONSE TO NUCLEOSIDE ANALOGS-BASED CHEMOTHERAPY
    Mitra, A. K.
    Ghosh, T. Mitra
    Feldberg, T. J.
    Pounds, S.
    Cao, X.
    Lamba, J. K.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 : S63 - S63
  • [22] Potent siRNA inhibitors of ribonucleotide reductase subunit RRM2 reduce cell proliferation in vitro and in vivo
    Heidel, Jeremy D.
    Liu, Joanna Yi-Ching
    Yen, Yun
    Zhou, Bingsen
    Heale, Bret S. E.
    Rossi, John J.
    Bartlett, Derek W.
    Davis, Mark E.
    CLINICAL CANCER RESEARCH, 2007, 13 (07) : 2207 - 2215
  • [23] Ribonucleotide reductase M2 subunit as novel target for liposarcoma
    Geha, Rula C.
    Wu, Vicotria
    DeCarolis, Penelope
    O'Connor, Rachael
    Chen, JinHong
    Schwartz, Gary
    Singer, Samuel
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2006, 203 (03) : S86 - S86
  • [24] Ribonulceotide Reductase M2 (RRM2): Predictive Marker of Response to Gemcitabine in Pancreatic Cancer
    Farrell, James J.
    Garcia, Miguel
    Liu, Xiyong
    Ammar, Ali
    Regine, William F.
    Abrams, Ross A.
    Elsaleh, Hany
    GASTROENTEROLOGY, 2009, 136 (05) : A32 - A32
  • [25] A NOVEL GALLIUM COMPOUND DISRUPTS TUMOR IRON HOMEOSTASIS AND RETARDS THE GROWTH OF GLIOBLASTOMA IN VIVO BY INHIBITING THE IRON-DEPENDENT M2 SUBUNIT OF RIBONUCLEOTIDE REDUCTASE (RRM2)
    Chitambar, Christopher
    Al-Gizawiy, Mona
    Lozen, Andrew
    Pechman, Kimberly
    Wereley, Janine
    Wujek, Robert
    Clark, Paul
    Kuo, John
    Elford, Howard
    Hedlund, Bo
    Joshi, Devashish
    Antholine, William
    Schmainda, Kathleen
    AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (08) : E213 - E213
  • [26] A Single Conserved Residue Mediates Binding of the Ribonucleotide Reductase Catalytic Subunit RRM1 to RRM2 and Is Essential for Mouse Development
    Specks, Julia
    Lecona, Emilio
    Lopez-Contreras, Andres J.
    Fernandez-Capetillo, Oscar
    MOLECULAR AND CELLULAR BIOLOGY, 2015, 35 (17) : 2910 - 2917
  • [27] The Clinical and Prognostic Significance of Ribonucleotide Reductase Subunits RRM1 and RRM2 mRNA Levels in Patients with Chronic Lymphocytic Leukemia
    Chatzidavid S.
    Kontandreopoulou C.-N.
    Diamantopoulos P.T.
    Giannakopoulou N.
    Katsiampoura P.
    Stafylidis C.
    Dryllis G.
    Kyrtsonis M.-C.
    Dimou M.
    Panayiotidis P.
    Viniou N.-A.
    Clinical Hematology International, 2023, 5 (2-3) : 92 - 100
  • [28] High Expression of Ribonucleotide Reductase Subunit M2 Correlates with Poor Prognosis of Hepatocellular Carcinoma
    Lee, Boin
    Ha, Sang Yun
    Song, Dae Hyun
    Lee, Hyun Woo
    Cho, Soo Youn
    Park, Cheol-Keun
    GUT AND LIVER, 2014, 8 (06) : 662 - 668
  • [29] Oxymatrine induces anti-tumor response in cervical cancer by modulating circ_0008460/miR-197-3p/ribonucleotide reductase subunit M2 (RRM2)
    Li, Siwei
    Zhang, Heng
    Jiao, Yunping
    Song, Xiao
    Wei, Lei
    Liu, Xing
    BIOENGINEERED, 2022, 13 (05) : 12912 - 12926
  • [30] Regulation of ribonucleotide reductase M2 expression by the upstream AUGs
    Dong, ZZ
    Liu, Y
    Zhang, JT
    NUCLEIC ACIDS RESEARCH, 2005, 33 (08) : 2715 - 2725
12345